# Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

> **NCT00004061** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 111 (estimated)

## Conditions studied

- Leukemia
- Lymphoma
- Oral Complications

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** palifermin
- **DRUG:** cyclophosphamide
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **PROCEDURE:** peripheral blood stem cell transplantation
- **PROCEDURE:** quality-of-life assessment
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00004061
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-05
- **Primary completion:** 2003-05
- **Final completion:** 2009-12
- **Target enrollment:** 111 (ESTIMATED)
- **Last updated:** 2013-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004061, "Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00004061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*